Pilot Deviation Avoidance

2016-01 gajsc logo headrer

General Aviation Joint Steering Committee

Pilot Deviation Avoidance

Outreach Guidance Document

2016/09/19-092 (I) PP

This outreach guidance is provided to all FAA and aviation industry groups that are participating in outreach efforts sponsored by the General Aviation Joint Steering Committee (GAJSC). It is important that all outreach on a given topic is coordinated and is free of conflicts. Therefore, all outreach products should be in alignment with the outline and concepts listed below for this topic.

Outreach Month: August 2017

Topic: Pilot Deviation Avoidance

The FAA and industry will conduct a public education campaign emphasizing the best practices for avoiding pilot deviations - particularly those deviations that contribute to runway incursions.

Background:

Pilot Deviations are increasing across the nation. There are several reasons for this increase including mandatory reporting requirements for ATC and the use of automated loss of separation and airspace incursion detection equipment.

Teaching Points:

  • Pilot Deviations are a serious matter because they can be precursors to collisions.
  • PDs frequently result from a lack of situational awareness, miscommunication, and misunderstanding. One or more of these factors may be involved in any PD
  • Illicit drugs always impair human performance.
  • Healthcare providers may prescribe drugs that could compromise pilots’ abilities - especially if the doctor is not aware that the patient is a pilot.
  • Combinations of prescription and OTC medications can be particularly dangerous. Pilots should consult their AME before taking a combination of medications.
  • AMEs are trained to advise pilots on negative and positive effects of drugs with respect to aviation.
  • Pilots must truthfully report all medical conditions and drug use on their medical application forms and should consult their AME with respect to all medical conditions and drug use before flight.


References:

Back to Top